EUVIMEDEUVIMED entdecken
Open Access

Tapcin, an In Vivo Active Dual Topoisomerase I/II Inhibitor Discovered by Synthetic Bioinformatic Natural Product (Syn‐BNP)‐Coupled Metagenomics

Zongqiang Wang, Amanda Kasper, Mai Takahashi, Adrian Morales Amador, Abir Bhattacharjee, Jingbo Kan, Yozen Hernandez, Melinda Ternei, Sean F Brady iD

Angewandte Chemie International Edition · 2024

DOI: 10.1002/anie.202317187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Zongqiang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Biological Products, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NINR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA topoisomerases are attractive targets for anticancer agents. Dual topoisomerase I/II inhibitors are particularly appealing due to their reduced rates of resistance. A number of therapeutically relevant topoisomerase inhibitors are bacterial natural products. Mining the untapped chemical diversity encoded by soil microbiomes presents an opportunity to identify additional natural topoisomerase inhibitors. Here we couple metagenome mining, bioinformatic structure prediction algorithms, and chemical synthesis to produce the dual topoisomerase inhibitor tapcin. Tapcin is a mixed p ‐aminobenzoic acid (PABA)‐thiazole with a rare tri‐thiazole substructure and picomolar antiproliferative activity. Tapcin reduced colorectal adenocarcinoma HT‐29 cell proliferation and tumor volume in mouse hollow fiber and xenograft models, respectively. In both studies it showed similar activity to the clinically used topoisomerase I inhibitor irinotecan. The study suggests that the interrogation of soil microbiomes using synthetic bioinformatic natural product methods has the potential to be a rewarding strategy for identifying potent, biomedically relevant, antiproliferative agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsAntineoplastic AgentsHumansMiceAnimalsTopoisomerase I InhibitorsTopoisomerase II InhibitorsDNA Topoisomerases, Type IDNA Topoisomerases, Type IIComputational BiologySoilThiazolesCell Line, Tumor

Stichwörter der Autor:innen

anticancermetagenomicsnatural productp-aminobenzoic acidsyn-BNP

Substanzen

Topoisomerase I InhibitorsTopoisomerase II InhibitorsDNA Topoisomerases, Type IBiological ProductsDNA Topoisomerases, Type IIAntineoplastic AgentsSoilThiazoles

Autor:innen und Institutionen

  • Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA.
  • Laboratory of Systems Cancer Biology, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA.

ORCID-Profile: Sean F Brady

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NINR NIH HHS
  • National Institute of Nursing Research

Zitieren

APA

Wang, Z., Kasper, A., Takahashi, M., Morales Amador, A., Bhattacharjee, A., Kan, J., Hernandez, Y., Ternei, M., & Brady, S. F. (2024). Tapcin, an In Vivo Active Dual Topoisomerase I/II Inhibitor Discovered by Synthetic Bioinformatic Natural Product (Syn‐BNP)‐Coupled Metagenomics. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202317187

Vancouver

Wang Z, Kasper A, Takahashi M, Morales Amador A, Bhattacharjee A, Kan J, et al. Tapcin, an In Vivo Active Dual Topoisomerase I/II Inhibitor Discovered by Synthetic Bioinformatic Natural Product (Syn‐BNP)‐Coupled Metagenomics. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202317187

BibTeX
@article{Wang2024,
  author = {Wang, Zongqiang and Kasper, Amanda and Takahashi, Mai and Morales Amador, Adrian and Bhattacharjee, Abir and Kan, Jingbo and Hernandez, Yozen and Ternei, Melinda and Brady, Sean F},
  title = {Tapcin, an In Vivo Active Dual Topoisomerase I/II Inhibitor Discovered by Synthetic Bioinformatic Natural Product (Syn‐BNP)‐Coupled Metagenomics},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  doi = {10.1002/anie.202317187}
}
Kostenlos starten →